BEQUBOND

Serial Number 90489163
606

Registration Progress

Application Filed
Jan 26, 2021
Under Examination
Nov 16, 2021
Approved for Publication
Sep 21, 2021
Published for Opposition
Sep 21, 2021
Registered

Trademark Image

BEQUBOND

Basic Information

Serial Number
90489163
Filing Date
January 26, 2021
Published for Opposition
September 21, 2021
Abandonment Date
December 23, 2024
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Dec 23, 2024
Classes
005

Rights Holder

Principia Biopharma Inc.

03
Address
55 Corporate Drive
Bridgewater, NJ 08807

Ownership History

Principia Biopharma Inc.

Original Applicant
03
South San Francisco, CA

Principia Biopharma Inc.

Owner at Publication
03
Bridgewater, NJ

Legal Representation

Attorney
Karen Lim

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

32 events
Date Code Type Description Documents
Dec 23, 2024 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Dec 23, 2024 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Apr 4, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 3, 2024 EXT5 S SOU EXTENSION 5 FILED Loading...
Apr 3, 2024 EX5G S SOU EXTENSION 5 GRANTED Loading...
Apr 3, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 30, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Sep 28, 2023 EX4G S SOU EXTENSION 4 GRANTED Loading...
Sep 28, 2023 EXT4 S SOU EXTENSION 4 FILED Loading...
Sep 28, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 24, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 22, 2023 EX3G S SOU EXTENSION 3 GRANTED Loading...
Mar 22, 2023 EXT3 S SOU EXTENSION 3 FILED Loading...
Mar 22, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 12, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 10, 2022 EX2G S SOU EXTENSION 2 GRANTED Loading...
Oct 10, 2022 EXT2 S SOU EXTENSION 2 FILED Loading...
Oct 10, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 16, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 14, 2022 EX1G S SOU EXTENSION 1 GRANTED Loading...
Apr 14, 2022 EXT1 S SOU EXTENSION 1 FILED Loading...
Apr 14, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 16, 2021 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Sep 21, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Sep 21, 2021 PUBO A PUBLISHED FOR OPPOSITION Loading...
Sep 1, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Aug 18, 2021 FIXD O ELECTRONIC RECORD REVIEW COMPLETE Loading...
Aug 13, 2021 ERRR O ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED Loading...
Aug 12, 2021 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Aug 12, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 27, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jan 29, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the prevention and treatment of immune-mediated, autoimmune, inflammatory, respiratory, and rare diseases and disorders; pharmaceutical preparations for preventing and treating diseases and disorders of the skin and blood; pharmaceutical preparations for preventing and treating lesions and tumors

Classification

International Classes
005